VRNA
Verona Pharma
VRNA
VRNA
Delisted
VRNA was delisted on the 6th of October, 2025.
151 hedge funds and large institutions have $1.95B invested in Verona Pharma in 2024 Q3 according to their latest regulatory filings, with 45 funds opening new positions, 42 increasing their positions, 48 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
151
Holders Change
+26
Holders Change %
+20.8%
% of All Funds
2.18%
Holding in Top 10
11
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+57.14%
% of All Funds
0.16%
New
45
Increased
42
Reduced
48
Closed
19
Calls
$24.3M
Puts
$27.6M
Net Calls
-$3.24M
Net Calls Change
-$3.55M
Top Buyers
| 1 |
PA
Perceptive Advisors
New York
|
+$112M |
| 2 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$54.6M |
| 3 |
MC
Maverick Capital
Dallas,
Texas
|
+$32.3M |
| 4 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$32M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$30.9M |
Top Sellers
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$75.5M |
| 2 |
O
OrbiMed
New York
|
-$41.4M |
| 3 |
CG
Carlyle Group
Washington,
District of Columbia
|
-$35.5M |
| 4 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
-$23.6M |
| 5 |
LCM
Laurion Capital Management
New York
|
-$15.2M |
